PPARGC1A and Insulin resistance: Additionally, MAE improves hepatic insulin resistance through inhibiting PGC-1α and FOXO1 transcriptional activity to decrease gluconeogenesis as well as suppressing JNK phosphorylation to enhance insulin signalling transduction.